Consequently, breaking the cross‐talk between T cells and keratinocytes by inhibiting glutaminase (GLS), a key enzyme in glutamine metabolism, or SLC1A3, a key transporter of aspartate uptake, alleviates psoriasis in a mouse model. This evidence concerns the gene SLC1A3 and psoriasis.